Clinical Trial

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-01-06; most recent amendment 2026-06-09.
Trial Details
NCT Number NCT07325253
Lead Sponsor M.D. Anderson Cancer Center
Conditions Pilot Study, PET/CT Imaging, Host Disease Manifestation
Enrollment 16 participants
Start Date 2025-11-18
Primary Completion 2028-01-03 (estimated)
Study Completion 2030-01-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-10